US 6849417
Mammalian selenoprotein differentially expressed in tumor cells
expired A61KA61K38/00
Quick answer
US patent 6849417 (Mammalian selenoprotein differentially expressed in tumor cells) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/00